NCT01673269View on ClinicalTrials.gov

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
CholedocholithiasisCholangiocarcinomaBenign Stricture of Common Bile Duct
Interventions
OTHER

Blood culture ( aerobic and anaerobic)

Blood culture 5 minutes and 30 minutes after the procedure

Trial Locations (1)

79905

Texas Tech University Health Sciences Center at El Paso, El Paso

All Listed Sponsors
collaborator

American College of Gastroenterology

OTHER

lead

Texas Tech University Health Sciences Center, El Paso

OTHER

NCT01673269 - Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD | Biotech Hunter | Biotech Hunter